NCT03323671

Preemptive Analgesia for Primary Dysmenorrhoea

Preemptive Analgesia for Primary Dysmenorrhoea: a Randomized Controlled Trial

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 84 (actual)
• Sponsor: Hanan Nabil · Academic / Other
• Sex: Female
• Age: 15 Years – 25 Years
• Healthy volunteers: Not accepted

Summary

Preemptive analgesia before the release of pain mediators

Detailed description

spasmodic dysmenorrhea is one of the most distressing symptoms in women. adolescents shows a usual absence from school . prostaglandin release is one of the most accepted theory responsible for spasmodic dysmenorrhea. Non steroidal anti inflammatory Drugs were proved to be one of the alternative medications for spasmodic dysmenorrhea. Getting the idea of what is called preemptive anesthesia by blocking the receptors before catching pain mediators the study participants will be divided randomly into 2 group group 1 receiving ttt 2 days before the anticipated menstruation and group 2 receiving ttt only during menstruation as analgesia

Conditions

• Primary Dysmenorrhea

Interventions

Type	Name	Description
DRUG	preemptive mefenamic acid	preemptive analgesia before menstrual pain
DRUG	mefenamic acid	mefenamic acid given only during menstruation

Timeline

• Start date: 2017-08-01
• Primary completion: 2017-12-01
• Completion: 2017-12-01
• First posted: 2017-10-27
• Last updated: 2017-12-19

Locations

1 site across 1 country: Egypt